Ionis Pharmaceuticals, Inc. Income Taxes Paid
Ionis Pharmaceuticals, Inc. (IONS) reported Income Taxes Paid of $1.20 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-07-29
- Ionis Pharmaceuticals, Inc. income taxes paid, net for the quarter ending 2026-06-30 was $1.21M, a 7005.88% increase year-over-year.
- Ionis Pharmaceuticals, Inc. income taxes paid, net for the quarter ending 2026-03-31 was -$8.00K.
- Ionis Pharmaceuticals, Inc. income taxes paid, net for the quarter ending 2025-12-31 was $22.00K.
- Ionis Pharmaceuticals, Inc. income taxes paid, net for the quarter ending 2025-09-30 was -$278.00K, a 447.50% decline year-over-year.
- Ionis Pharmaceuticals, Inc. income taxes paid, net for fiscal 2025 was -$639.00K.
- Ionis Pharmaceuticals, Inc. income taxes paid, net for fiscal 2024 was -$5.62M, a 111.63% decline from fiscal 2023.
- Ionis Pharmaceuticals, Inc. income taxes paid, net for fiscal 2023 was $48.33M, a 864.75% increase from fiscal 2022.
- Ionis Pharmaceuticals, Inc. income taxes paid, net for fiscal 2022 was $5.01M.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $1.20M 10-Q · filed 2026-07-29 | $1.22M derived: sum of 3 quarters · filed 2026-07-29 | $944.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | -$8.00K 10-Q · filed 2026-04-29 | $14.00K derived: sum of 2 quarters · filed 2026-04-29 | -$264.00K derived: sum of 3 quarters · filed 2026-04-29 | -$247.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$256.00K derived: sum of 2 quarters · filed 2026-02-26 | -$239.00K derived: sum of 3 quarters · filed 2026-07-29 | -$639.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | -$278.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$261.00K derived: sum of 2 quarters · filed 2026-07-29 | -$661.00K 10-Q · filed 2025-10-29 | -$8.35M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$383.00K 10-Q · filed 2026-07-29 | -$8.07M derived: sum of 3 quarters · filed 2026-07-29 | -$8.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | -$400.00K 10-Q · filed 2026-04-29 | -$8.09M derived: sum of 2 quarters · filed 2026-04-29 | -$8.01M derived: sum of 3 quarters · filed 2026-04-29 | -$6.03M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | -$7.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$7.61M derived: sum of 2 quarters · filed 2026-02-26 | -$5.63M derived: sum of 3 quarters · filed 2026-02-26 | -$5.62M 10-K · filed 2026-02-26 |
| 2024-09-30 | $80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $2.06M derived: sum of 2 quarters · filed 2025-10-29 | $2.07M 10-Q · filed 2025-10-29 | |
| 2024-06-30 | $1.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $1.99M 10-Q · filed 2025-07-30 | ||
| 2024-03-31 | $13.00K 10-Q · filed 2025-04-30 | |||
| 2023-12-31 | $48.33M 10-K · filed 2026-02-26 | |||
| 2022-12-31 | $5.01M 10-K · filed 2025-02-19 | |||
| 2020-12-31 | $25.86M 10-K · filed 2021-02-24 | |||
| 2019-12-31 | $9.04M 10-K · filed 2021-02-24 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-24 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-03-02 | |||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $0.00 derived: sum of 2 quarters · filed 2014-11-07 | $0.00 10-Q · filed 2014-11-07 | $0.00 derived: sum of 4 quarters · filed 2014-11-07 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $0.00 10-Q · filed 2014-08-04 | $0.00 derived: sum of 3 quarters · filed 2014-08-04 | $0.00 derived: sum of 4 quarters · filed 2014-11-07 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-06 | $0.00 derived: sum of 2 quarters · filed 2014-05-06 | $0.00 derived: sum of 3 quarters · filed 2014-11-07 | $0.00 derived: sum of 4 quarters · filed 2014-11-07 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $0.00 derived: sum of 2 quarters · filed 2014-11-07 | $0.00 derived: sum of 3 quarters · filed 2014-11-07 | $2.00K 10-K · filed 2014-03-03 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $0.00 derived: sum of 2 quarters · filed 2014-11-07 | $2.00K 10-Q · filed 2014-11-07 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $2.00K 10-Q · filed 2014-08-04 | ||
| 2013-03-31 | $2.00K 10-Q · filed 2014-05-06 | |||
| 2012-12-31 | $2.00K 10-K · filed 2014-03-03 | |||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $0.00 derived: sum of 2 quarters · filed 2014-03-03 | $0.00 derived: sum of 3 quarters · filed 2014-03-03 | $2.00K 10-K · filed 2014-03-03 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $0.00 derived: sum of 2 quarters · filed 2012-11-06 | $2.00K 10-Q · filed 2012-11-06 | -$428.00K derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $2.00K 10-Q · filed 2012-08-06 | -$428.00K derived: sum of 3 quarters · filed 2013-02-28 | -$428.00K derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | $2.00K 10-Q · filed 2012-05-09 | -$428.00K derived: sum of 2 quarters · filed 2013-02-28 | -$428.00K derived: sum of 3 quarters · filed 2013-02-28 | -$428.00K derived: sum of 4 quarters · filed 2013-02-28 |
| 2010-12-31 | -$430.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$430.00K derived: sum of 2 quarters · filed 2013-02-28 | -$430.00K derived: sum of 3 quarters · filed 2013-02-28 | $7.27M 10-K · filed 2013-02-28 |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $0.00 derived: sum of 2 quarters · filed 2011-11-08 | $7.70M 10-Q · filed 2011-11-08 | $10.70M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $7.70M 10-Q · filed 2011-08-08 | $10.70M derived: sum of 3 quarters · filed 2012-02-29 | $14.10M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-03-31 | $7.70M 10-Q · filed 2011-05-06 | $10.70M derived: sum of 2 quarters · filed 2012-02-29 | $14.10M derived: sum of 3 quarters · filed 2012-02-29 | |
| 2009-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $6.40M derived: sum of 2 quarters · filed 2012-02-29 | $13.21M 10-K · filed 2012-02-29 | |
| 2009-09-30 | $3.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $10.21M 10-Q · filed 2010-11-05 | ||
| 2009-06-30 | $6.80M 10-Q · filed 2010-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |